More articles from Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Probes for Oncology

You have access
[¹⁸F]PEG-Biotin labeled nanoparticles for tracking drug delivery and tumor therapy
MingQiang Zheng, Rachael Sirianni, Toral Patel, Jiangbing Zhou, Jim Ropchan, W. Mark Saltzman, Richard Carson and Yiyun Huang

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 417;
You have access
PET imaging of insulinoma using ¹⁸F-FBEM-EM3106 B, a new GLP-1 analog
Hao Gao, Gang Niu, Min Yang, Qimeng Quan, Ying Ma, Jung-Mo Ahn, Xiankai Sun, Dale Kiesewetter and Xiaoyuan Chen

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 413;
You have access
¹⁸F-FAHA PET for imaging histone deacetylase in lung cancer
Wayland Tang, Valentin Galitovskiy, Evegueni Sevrioukov, Min-Liang Pan, Cristian Constantinescu, Sergei Grando and Jogeshwar Mukherjee

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 411;
You have access
BAY 94-9392 - A novel F-18 L-glutamate derivative for tumor-specific PET imaging
Norman Koglin, Andre Mueller, Mathias Berndt, Heribert Schmitt-Willich, Volker Gekeler, Matthias Friebe and Ludger Dinkelborg

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 412;
You have access
Initial clinical trials of carbon-11-labeled 4DST in brain tumors
Jun Toyohara, Tadashi Nariai, Muneyuki Sakata, Keiichi Oda, Kenji Ishii, Takuya Kawabe, Toshiaki Irie, Tsuneo Saga, Kazuo Kubota and Kiichi Ishiwata

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 414;
You have access
First human study of N-(2-(diethylamino)ethyl)-6-[F-18]fluoropyridine-3-carboxamide (MEL050)
Robert Ware, Damien Kee, Grant McArthur, Silvana Brglevska, Jason Callahan, Andrew Katsifis, Peter Roselt, Thomas Bourdier and Rodney Hicks

Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 415;

Main menu

User menu

Search

More articles from Molecular Targeting Technologies - Radioactive and Nonradioactive Probes: Probes for Oncology

Pages